Resistance of Salmonella and Campylobacter bacteria to commonly used antimicrobials continues to be observed frequently in humans and animals, according to a report issued today by EFSA and ECDC.
Campylobacteriosis and salmonellosis were the most frequently reported zoonotic diseases in humans in the EU in 2022. For West Nile virus, an increase of the number of infections was observed.
EU/EEA countries are reporting an increased number of Escherichia coli (E. coli) isolates carrying the blaNDM-5 gene that makes them resistant to carbapenems, antibiotics.
Between 2018 and 2020, nearly 20 000 surgical site infections (SSIs) were reported from a total of over 1.2 million surgical procedures in 13 EU/EEA countries participating in ECDC-coordinated SSI surveillance. Over 2 500 hospitals are part of this surveillance network.
The number of reported human cases of illness caused by Campylobacter and Salmonella bacteria across Europe appears to have stabilised over the past five years, according to the latest report on zoonotic diseases by EFSA and ECDC.
The global rise of carbapenemase-producing Enterobacteriaceae (CPE) is alarming and is an increasing threat to patient safety, in Europe and globally.
On 8 March, the Health Protection Agency in the United Kingdom reported an additional fatal case of anthrax in Suffolk, England. It concerns a person who injected heroin. This brings the number of anthrax cases among injecting drug users in the EU to 14, since June 2012.